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A practical approach to diagnosing pleural effusion in 
southern Africa
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Excessive fluid accumulating within the 
pleural space is a common medical aiction 
and invariably indicates disease.[1,2] Under 
physiological conditions uid enters and exits 
the pleural space at the same rate.[3] e rate of 
production is determined by Starling’s forces, 
i.e. hydrostatic pressure, osmotic pressure and 
membrane permeability, whereas the exit rate 
is determined by clearance through lymphatic 
drainage.[3] Alterations in any of these forces 
can lead to the formation of a pleural eusion. 
While the physiological amount of pleural 
uid present has various positive eects on 
respiratory function, e.g. assisting in creating 
a negative intrathoracic pressure and reducing 
friction between pleural membranes, 
excessive uid can signicantly impair normal 
respiratory function. Once the volume of uid 
in the pleural space reaches 200 - 250 ml, it is 
detectable on a standard PA chest radiograph 
(CXR). e presence of a pleural eusion 
can be clinically detected only aer the uid 
volume reaches 300 - 350 ml,[4] but in the event 
of small volumes the sensitivity and specicity 
in its detection rates remain low.[5]  Because the 
dierential diagnosis for intrapleural uid 
accumulation encompasses a wide spectrum 
of conditions, a systematic approach to these 
eusions is particularly important in their 
investigation. 
Aetiology
e causes of pleural eusions can be classied 
as either a transudate (Table 1) or an exudate 
(Table 2).[1,6] e most common causes of a 
transudate are congestive cardiac failure 
(CCF) and hepatic cirrhosis,[6] while the most 
common exudative eusions are caused by 
Mycobacterium tuberculosis (MTB) infection, 
malignancy or bacterial pneumonia.[2,6] In the 
case of a bilateral eusion the spectrum of 
dierential diagnoses is narrower than that 
of a unilateral eusion. Bilateral eusions are 
commonly caused by CCF, hypoalbuminaemic 
states, renal failure and, rarely, malignancies, 
rheumatic arthritis or pulmonary embolisms. 
Dierentiating the cause of a pleural eusion 
is greatly aided by careful history taking and 
physical examination, assisted by various 
targeted special investigations.[1]
Clinical presentation
Patients oen present with a cough, dyspnoea 
and a pleuritic type of chest pain when suering 
from a pleural eusion.[7] A history of cardiac, 
liver or renal failure may suggest a transudate, 
whereas a history of a recent diagnosis of 
a malignancy would suggest a malignant 
eusion. Similarly, a preceding history of deep 
vein thrombosis suggests an eusion related 
to a pulmonary embolism and constitutional 
symptoms of MTB, or a household contact 
with cavitating MTB infection could point to 
a tuberculous eusion. Additionally, history 
taking should explore recent surgery or 
trauma and a complete occupational history 
including exposure to asbestos and a review of 
medications used (Table 3).[1] Physical ndings 
could also aid in the diagnostic work-up – 
identifying the presence of ascites may suggest 
MTB infection, cirrhosis or malignancies, 
e.g. ovarian carcinomas. e clinician usually 
progresses from considering the possibility of a 
pleural eusion on examination to conrming 
its presence by requesting either a CXR or 
performing an ultrasound examination. 
Radiology 
Chest radiograph
e plain PA CXR, although not specic, 
has various features suggesting the presence 
of a pleural eusion. Depending on the size 
of the eusion, these features can vary from 
blunting of the costophrenic angle (Fig. 1) 
to loss of the diaphragmatic silhouette and, 
ultimately, to a complete white-out of a 
hemi-thorax (Fig. 2).[1] Other features that 
may be present are the displacement of the 
trachea to the contralateral side of the eusion 
(Fig. 2), features suggestive of a subpulmonic 
eusion (lateral peaking of an apparently 
raised hemidiaphragm) (Fig. 1) or the hazy 
appearance of the lung, oen referred to as 
the ‘veiled’ lung.[1]  e CXR can also be helpful 
Table 1. Causes of a transudate
Frequent •	 Congestive cardiac 
failure
•	 Hypoalbuminaemia
•	 Peritoneal dialysis 
•	 Liver failure
Infrequent  •	 Hypothyroidism
•	 Nephrotic syndrome
•	 Pulmonary embolism
•	 Urinothorax
•	 Pericardial 
constriction
•	 Mitral valve stenosis
Table 2. Causes of an exudate
Frequent •	 Tuberculosis
•	 Malignancy
•	 Parapneumonic 
eusions 
Infrequent  •	 Rheumatoid and 
other autoimmune 
disorders
•	 Post-myocardial 
infarct syndrome
•	 Post-coronary 
artery bypass
•	 Asbestos-related 
eusion
•	 Pancreatitis
•	 Drugs (Table 3)
Table 3. Drugs associated with 
pleural eusions
 Rare •	 Amiodarone
•	 Phenytoin
•	 Methotrexate 
 Very rare •	 Carbamazepine
•	 Cyclophosphamide
•	 Penicillamine
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in determining the cause of the eusion.[2] 
Where an eusion and a mass lesion or 
hilar adenopathy are present on the CXR, 
a malignant eusion should be included in 
the dierential diagnosis. However, the CXR 
oen fails in determining the presence of 
locutions or septations within the eusion 
or in the detection of pleural thickening and 
brosis. is is where either a decubitus CXR 
or an ultrasound examination can aid in the 
evaluation.[1]
Transthoracic ultrasound
Ultrasound examination is very sensitive 
in detecting effusions and accurate in 
determining the size and other features of 
the eusion.[8,9] It has the advantage of the 
instrumentation being portable and the 
technique safe to perform.[8] e eusion 
is identied as an anechoic area between 
the visceral and parietal pleura (Fig. 3).[10] 
Exudates can also display a homogeneous 
echogenic pattern.[1] Depending on the 
size of the eusion, the operator can also 
identify the collapsed lung in the eusion 
or the presence of septations (Fig. 4), 
loculations and pleural thickening.[10] 
Ultrasonic features can also suggest the 
aetiology of a lesion, e.g. a malignancy 
(Fig. 5). is  technique has a superior 
sensitivity to computed tomography (CT) in 
determining subtle features of an eusion, 
such as pleural thickening.[8]
Computed tomography of the chest
A chest CT scan is not indicated in the 
initial work-up of all patients who present 
with a pleural eusion.[8] e CT scan allows 
imaging of the underlying lung parenchyma 
and the mediastinum, thereby assisting 
in determining the aetiology (Fig. 6).[6] A 
further indication would be a dicult-to-
drain eusion; here CT scanning is helpful 
in determining the size and location of 
the eusion. A CT scan, using a contrast 
medium, should therefore be requested in 
selected cases aer the initial diagnostic 
work-up has indicated a need for further 
imaging. 
Thoracentesis
Indication and evaluation 
oracentesis and uid analysis is a low-risk, 
cost-eective procedure that can rapidly 
narrow down the differential diagnosis.[3] 
Therefore, it should be performed in all 
cases of an effusion of >10  mm on CXR 
or ultrasound.[6,8] An exception is a pleural 
eusion associated with clinical features of 
cardiac failure where the eusion decreases 
in size and fully resolves aer initiation of 
diuretic therapy.[1,6] e initial thoracocentesis 
is oen done for diagnostic purposes, except 
when the patient complains of shortness of 
breath at rest, where it could also be done for 
therapeutic benet.
Once aspirated, uid should be sent to the 
laboratory (Table 4) for cytology, cell counts, 
microbiology and biochemical analysis.
Fig. 1. A chest radiograph showing a 
subpulmonic eusion (E), with lateral 
peaking (A) of the apparent hemidiaphragm, 
with associated features including a steep 
lateral and gradual medial slope of this 
apparent diaphragm. Additionally, there 
is loss of the costophrenic angle and the 
eusion is visible on the lateral aspect (B). 
Fig. 2. A chest radiograph showing a 
massive le-sided eusion with midline 
shi to the right.
Fig. 3. is transthoracic ultrasound image 
clearly shows a hypo-echoic area representing 
a pleural eusion (E) between the chest wall 
(CW) and atelectatic lung (L).
Fig. 4. A transthoracic ultrasound scan 
yielding evidence of a pleural eusion (E) 
with septations (S) and loculations (L).
Fig. 5. A transthoracic ultrasound scan 
of patient with an eusion (E), where a 
malignant pleural nodule (N) is visible on the 
parietal pleura.
Fig. 6. A computed tomography scan showing 
right hilar lymph adenopathy (arrow) and a le-
sided pleural eusion (E) with a collapsed lung (L).
322  CME  September  2013  Vol. 31  No. 9
Pleural eff usion
Macroscopic appearance 
A er performing a thoracocentesis the odour 
and macroscopic appearance should be noted. A 
foul-smelling odour suggestive of an anaerobic 
infection can guide antibiotic choice.[1]  e 
macroscopic evaluation of the aspirated  uid 
frequently further contributes to narrowing 
down the di erential diagnosis.  e appearance 
of the aspirate is divided between that of blood 
stained, frank blood, serous, purulent and 
chylous.[1,3] Although not speci c, these features 
may suggest an underlying cause (Table 5). 
Routine chemistry
Laboratory tests must include pH 
measurement,  uid protein concentration, 
lactate dehydrogenase (LDH), albumin 
and adenosine deaminase (ADA) levels.[3,6] 
Concurrently, the serum protein and LDH 
levels should be determined for comparison 
with pleural  uid values.[1,3,6]   is chemical 
analysis helps to determine whether the  uid 
is an exudate or a transudate by applying the 
modi ed Light’s criteria (Table 6). A pleural 
e usion with a protein level >30 g/l together 
with a  uid protein ratio >0.5 is indicative 
of an exudate.[3] Using only protein levels 
to di erentiate between a transudate and 
an exudate will erroneously result in the 
classification of 15% of transudates and 
10% of exudates.[1] Light’s criteria should 
therefore always be used to di erentiate 
between transudates and exudates, especially 
when the  uid protein level is 25 - 35 g/l.[6] 
 is will correctly identify all exudates, but 
it could classify up to 20% of transudates 
as exudates.[3]  is error in classi cation 
can be corrected for by determining the 
protein gradient of the  uid to either serum 
protein or albumin levels. If the di erence 
between protein levels of the effusate 
and serum is >31  g/l or the di erence in 
albumin is >12 g/l, those exudates should be 
considered  transudates.[3]  ese gradients 
should however not be used on their own 
to determine the classi cation, as this will 
lead to errors in up to 30% of cases.[6]  e 
LDH level, in addition to its use as part of the 
Light’s criteria, can also indicate the presence 
of empyema if it is >1 000 U/l. As part of 
the Light’s criteria, an LDH of >2/3 of the 
upper limit of the laboratory normal or a 
 uid to serum LDH ratio of >0.6 indicates 
an exudate.[1] 
pH
A pleural  uid pH measurement should be 
performed on all non-purulent e usions.[1] Where 
a pH value of <7.2 is found this may be 
indicative of a complicated parapneumonic 
e usion or empyema and should prompt 
the insertion of an intercostal chest drain 
to clear the fluid and obtain source 
control.[11,12] Other less frequent causes of 
a low pH include rheumatic arthritis, 
malignancies, oesophageal rupture and 
sample contamination with lignocaine. 
In addition to the elevated LDH and low 
pH values, parapneumonic e usions are 
neutrophil predominant. 
Adenosine deaminase
Fluid ADA level is of particular use where 
TB is highly endemic. ADA levels >40 IU/l,[9] 
in conjunction with a lymphocytic pre-
dominance, is highly sensitive but may have 
sub-optimal speci city (70 - 90% depending 
on the study referred to and the cut-o  point 
used) for TB pleural e usions.[8,9] Other causes 
Table 4. Analysis of pleural  uid 
aspirates should include the 
following:
Basic •	 Stains for AFB, TB 
culture
•	 Bacterial MCS
•	 Cytology 
•	 Di erential cell 
count
•	 ADA
•	 LDH
•	 Protein
 Additional •	 Albumin
•	 Glucose
•	 IFN-γ
•	 Fungal culture
•	 Lipid analysis
•	 Haematocrit                                 
•	 Amylase
•	 Tumour markers
•	 Complement C4 
level
AFB = acid-fast bacilli; MCS = microscopy, culture 
and sensitivity; ADA= adenosine deaminase; 
LDH = lactate dehydrogenase; PCR = polymerase 
chain reaction; IFN = interferon. 
Table 5. Macroscopic appearance 
of pleural e usions
 Straw colour •	 Tuberculosis
•	 Transudates
•	 Simple 
parapneumonic 
e usion 
•	 Benign 
asbestos-related 
e usion
Chylous •	 Neoplasms
•	 Trauma
•	 Tuberculosis
•	 Sarcoidosis
•	 Amyloidosis
•	 Neoplasm
Bloody •	 Trauma
•	 Pulmonary 
embolism
•	 Post-cardiac 
injury
Purulent •	 Tuberculosis
•	 Empyema
In the case of a bilateral 
e usion the spectrum of 
di erential diagnoses is 
narrower than that of a 
unilateral e usion.
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of an elevated ADA include malignancies, 
empyema and rheumatoid arthritis (RA).[8,9] 
HIV infection can, however, cause false low 
ADA levels despite co-infection with TB.[3] 
In selected cases, direct measurement of 
unstimulated interferon-gamma (IFN-γ) 
levels in pleural uid can conrm MTB 
infection with a sensitivity and specicity 
of >90%.[13,14]  Unfortunately this test, despite 
being very sensitive, is costly and should be 
reserved for highly selected cases only. e 
IFN-γ-release assay (IGRA), which measures 
T cell release of IFN-γ following stimulation 
by antigens unique to MTB, has been proven 
to be ineffective and inconsistent when 
performed on pleural uid.[15,16] 
Additional biochemical analysis
Additional biochemical tests that are 
useful include pleural uid glucose levels, 
cholesterol or lipid levels and amylase 
measurements. Pleural exudates with a 
glucose level <3.3 mmol/l are probably due 
to an empyema, RA, lupus, TB, malignancy 
or rarely oesophageal rupture.[3,6] With 
RA effusions, the glucose level is often 
1.6  mmol/l.[3] An amylase measurement in 
pleural uid higher than that of serum[2] 
suggests pancreatitis, pancreatic pseudocyst or 
a ruptured viscus as the cause of the exudate.[1] 
An elevated amylase level can also be caused 
by approximately 10% of malignancies. Lipid 
analysis of the pleural uid can discriminate a 
pseudochylothorax from a true chylothorax.[2] 
e latter will typically have a high triglyceride 
level (>1.24 mmol/l) and can be excluded if 
the triglyceride level is low (<0.56 mmol/l).[1] A 
pseudochylothorax is characterised by an 
elevated cholesterol level (>5.18 mmol/l) 
in the absence of chylomicrons in the 
uid.[1] A chylous eusion is usually related 
to malignancies, or surgically or otherwise 
traumatised thoracic duct or its tributaries, 
but it can also be caused by TB or sarcoidosis.[1] 
Differential cell count
Causes of a neutrophil-predominant eusion 
include acute MTB infection (up to 20% of 
cases in some series), pulmonary embolism 
and benign asbestos-related eusions.[17] A 
pleural uid predominated by lymphocytes 
occurs in various disorders including TB, 
lymphomas or other malignancies, RA and 
chylothorax.[3] Eosinophilic predominance, 
dened as the presence of ≥10% eosinophils, 
carries little diagnostic signicance as >30% 
of these eusions remain undiagnosed, but 
at times these eusions are caused by air or 
blood in the pleural space,[3,6] drug reactions, 
TB and parasitic infections (Table 7).[1]
Microbiology
Microbiological evaluation of the pleural 
uid should include Ziehl-Neelsen and Gram 
staining and liquid cultures for MTB and other 
bacteria.[1] Recently, the GeneXpert® test for 
use on pleural uid has become available. is 
polymerase chain reaction (PCR)-based test is 
accurate, with a high sensitivity and specicity 
for detecting active MTB in sputum. It has the 
additional benet of testing for rifampicin 
resistance and serves as a surrogate for 
determining multidrug resistance in the 
setting of MTB infection. However, it should 
not be used for the routine diagnosis of TB 
pleural eusion as its sensitivity is low (~25% 
in over 100 suspected cases of TB pleural 
eusion according to unpublished data by R 
Meldau et al.). An additional antigen assay for 
detecting Streptococcus pneumonia in pleural 
uid is commercially available,[18] but it is not 
recommended for routine use because of its 
limited therapeutic benet and cost. 
Cytology
Cytological evaluation is particularly 
important if a malignancy is expected. e 
sensitivity of cytology on a single sample is 
around 60%[3] and yield increases if both cell 
blocks and smears are used.[6] Sensitivity is, 
however, dependent to some extent on the 
type of malignancy involved. Mesotheliomas, 
for instance, are only reliably detected in 
about 10% of cases compared with the 
adenocarcinoma detection rate of up to 
70%.[6] 
Pleural biopsy
Blind biopsy of the pleura adds little 
to cytological investigation in terms of 
diagnosing pleural malignancies. Ultrasound-
guided biopsies, however, may be utilised in 
patients with suspected malignancies where 
the cytology remains negative or in cases with 
suspected pleural TB.[8] 
Ultrasound-guided pleural biopsy
ese biopsies, performed using an Abrams 
needle, are of greatest value in diagnosing 
granulomatous disorders and malignancies, 
including mesotheliomas. Whenever a pleural 
biopsy is done, tissue should be sent for TB 
culture smear and acid-fast bacilli (AFB) 
tests. Further tests should include histology, 
electron microscopy and bacterial cultures. 
When these investigations are collectively 
performed, biopsy has a diagnostic yield of up 
to 90%.[8,10] Biopsy specimens should be taken 
at the area of maximal pleural thickening or 
nodularity as identied by ultrasound.[8,10] In 
the event that no nodularity or thickening 
can be identied, a biopsy can be taken at the 
safest point, as determined by deepest uid 
collection on ultrasound, when suspecting 
TB.[8] If a malignancy is suspected, the biopsy 
Table 6. Modied Light’s criteria
Pleural uid is an exudate if one or more of the following criteria are met:
Pleural uid 
•	 Serum protein ratio >0.5
•	 Serum LDH ratio >0.6
•	 LDH  >2/3 upper limit of normal serum LDH
•	 Protein >30 g/l
If only one of the above criteria is met, then calculate the uid to serum albumin gradient
•	 If the albumin gradient >12 g/l, consider a transudate
LDH = lactate dehydrogenase.
Table 7. Aetiologies associated 
with dierential cell counts
 Neutrophilic •	 Parapneumonitis
•	 Pancreatitis
•	 Pulmonary 
embolus 
•	 Malignancy (rare)
•	 Acute tuberculosis
Lymphocytic •	 Tuberculosis
•	 Lymphomas
•	 Other malignancies
•	 Rheumatoid 
arthritis
Eosinophilic •	 Drug reactions
•	 Parasitic infection
•	 Tuberculosis (rare)
•	 Pneumothorax
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should be taken as low or near to the diaphragm as safely possible, 
because malignant cells accumulate at the bases. When taking a biopsy 
from a suspected mesothelioma, the site should be marked as there 
is a risk of cellular seeding through the biopsy tract. To prevent this, 
radiation to the site will be required within one month of the biopsy.[1] 
Other complications of an Abrams needle biopsy include pain, vasovagal 
reactions, haematomas and haemothorax.[8]
Thoracoscopy
If the cause of a pleural exudate remains unclear despite repeated 
thoracentesis with appropriate evaluation followed by an ultrasound-
guided core needle/Abrams needle biopsy as described above, the next 
step would be to o er the patient a medical or surgical thoracoscopy.[8] 
Both these procedures, the prior performed by a pulmonologist and the 
latter by a thoracic surgeon, have a diagnostic yield for MTB reaching 
100% and >90% for cancer, respectively.[8]
Persistent undiagnosed effusions
Despite repeated cytology, pleural biopsies and thoracoscopy, the cause of 
persistent undiagnosed e usions remains unknown in a small percentage 
of cases.[1] In this setting it is recommended that one reconsiders treatable 
causes such as TB, fungal infections and pulmonary embolism.[1] If these 
have been excluded, a watch and wait approach could be followed while 
o ering symptomatic treatment as needed. Many of these undiagnosed 
pleural e usions will eventually be attributable to malignancies.[1]
A practical approach in the 
southern African context
Once a patient presents to the primary healthcare practitioner with 
a history and physical examination suggestive of a pleural e usion, 
a con rmatory CXR should be done. Signi cant shortness of breath 
or mediastinal displacement should prompt therapeutic drainage. In 
most cases, however, these features are not present, and a calculated 
stepwise approach to diagnosing the problem should be followed 
(Fig. 7). A diagnostic thoracocentesis (ideally under ultrasound 
guidance) should be undertaken to determine the  uid LDH, 
protein, and ADA levels. Furthermore, cell counts, microscopy, 
culture and sensitivity (MCS) tests should be performed. It has also 
been suggested that serum LDH and protein levels must be done for 
comparison. Glucose level determinations in pleural  uid can also be 
bene cial in some cases.  e modi ed Light’s criteria should be used 
to classify the  uid as either an exudate or a transudate. 
History, physical examination and
radiology conrm a pleural eusion
Respiratory
or
circulatory
compromise
Features
suggestions
of
transudate?
Treat the cause
Therapeutic tap/ICD
Pleural aspiration,
uid for cytology,
protein LDH, pH, ADA,
MCS, TB MCS
Resolved
Empyema
chylothorax or
haemothorax?
Consider:
-Fluid cholesterol
-Triglycerides
-Haematocrit
-Centrifuge
-MCS
Likely cause
identied
Refer to a 
pulmonologist Resolved
Treat the cause
Exudate
Transudate
End
No Yes
No
No
No
No
NoYes
Yes
Yes
Yes
Yes
Fig. 7. An initial diagnostic approach to a pleural e usion (adapted from Maskell and Butland[1]) (MCS = microscopy, culture and sensitivity; 
LDH = lactate dehydrogenase; ADA = adenosine deaminase; ICD = implantable cardioverter de brillator).
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With a transudate, it is reasonable to treat the 
most likely cause and review the resolution 
of the e usion. Most exudates in southern 
Africa are secondary to pneumonia, TB and 
pleural malignancies. Pleural TB, for example, 
classically presents with a straw-coloured, 
lymphocyte-predominant exudate with an 
ADA >40 IU/l. It may be reasonable to treat 
and review the patient (even in the absence 
of microbiological confirmation), but the 
drawback of this approach is the potentially 
unnecessary drug toxicity and failure to treat 
appropriately in the case of drug-resistant TB. 
 e latter is a serious consideration, given that 8 
- 10% of TB cases will be drug resistant. Purulent 
e usions with a low pH should be drained 
using an intercostal drain or thoracic surgery, 
and appropriate antibiotic treatment started. 
Cases of suspected malignant e usions warrant 
specialist referral. Patients with undiagnosed, 
chylous or haemorrhagic e usions should also 
be referred for further evaluation, and should 
undergo additional investigations, which may 
include a repeat thoracocentesis, ultrasound-
guided pleural biopsy or thoracoscopy (Fig. 8).
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Summary
•	 Excessive  uid accumulating within the pleural space is a common medical problem and invariably indicates disease. 
•	 A structured approach with thoracocentesis as the  rst step is indicated in almost all cases.
•	 An e usion should be classi ed as either an exudate or a transudate using the modi ed Light’s criteria. 
•	 Transudates may be followed up conservatively (awaiting resolution), but exudates need further evaluation of the pleural  uid and possible 
sampling of pleural tissue. 
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Fig. 8. A suggested diagnostic approach to an undiagnosed pleaural e usion (CT = computed 
tomography; PE = pleural e usion; EM = electron microscopy; MCS = microscopy, culture and 
sensitivity).
